DE68918189T2 - Neisseria-Vakzine. - Google Patents

Neisseria-Vakzine.

Info

Publication number
DE68918189T2
DE68918189T2 DE68918189T DE68918189T DE68918189T2 DE 68918189 T2 DE68918189 T2 DE 68918189T2 DE 68918189 T DE68918189 T DE 68918189T DE 68918189 T DE68918189 T DE 68918189T DE 68918189 T2 DE68918189 T2 DE 68918189T2
Authority
DE
Germany
Prior art keywords
neisseria
vaccine
neisseria vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918189T
Other languages
English (en)
Other versions
DE68918189D1 (de
Inventor
Emil Claus Gotschlich
Milan Scott Blake
Lee Mark Wetzler
John Michael Koomey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Application granted granted Critical
Publication of DE68918189D1 publication Critical patent/DE68918189D1/de
Publication of DE68918189T2 publication Critical patent/DE68918189T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/821Microorganisms used in the destruction of hazardous or toxic waste
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE68918189T 1988-06-29 1989-06-29 Neisseria-Vakzine. Expired - Fee Related DE68918189T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21278688A 1988-06-29 1988-06-29

Publications (2)

Publication Number Publication Date
DE68918189D1 DE68918189D1 (de) 1994-10-20
DE68918189T2 true DE68918189T2 (de) 1995-01-12

Family

ID=22792421

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918189T Expired - Fee Related DE68918189T2 (de) 1988-06-29 1989-06-29 Neisseria-Vakzine.

Country Status (4)

Country Link
US (1) US6664094B1 (de)
EP (1) EP0351604B1 (de)
CA (1) CA1338708C (de)
DE (1) DE68918189T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
CA2147877A1 (en) * 1992-10-26 1994-05-11 Robert J. Arko Immunization against neisseria gonorrhoeae and neisseria meningitidis
EP0624376B1 (de) * 1993-05-13 2000-03-15 American Cyanamid Company Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577527A (en) * 1969-01-27 1971-05-04 Us Navy Neisseria meningitidis antigen
FR2308337A1 (fr) * 1975-04-22 1976-11-19 Sambardy Charles Support de pot de fleurs ou d'objets decoratifs
US4461838A (en) 1975-04-25 1984-07-24 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
US4696896A (en) * 1975-04-25 1987-09-29 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
AR220161A1 (es) 1977-12-20 1980-10-15 Merck & Co Inc Metodo para la obtencion de complejo antigeno de n.gonorrhoeae
US4203971A (en) 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
US4351761A (en) 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4241045A (en) 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4208480A (en) 1978-08-23 1980-06-17 American Home Products Corporation Method, reagents and apparatus for the rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis
US4220638A (en) 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4239749A (en) 1979-09-27 1980-12-16 United States Of America Neisseria gonorrhoeae vaccine
US4330623A (en) 1980-02-19 1982-05-18 Merck & Co., Inc. Process for solubilization of gonococcal antigen
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
US4446230A (en) 1981-10-30 1984-05-01 Temple University Of The Commonwealth System Of Higher Education Test method for the laboratory diagnosis of Gonorrhea and test strain of neisseria gonorrhoeae
AU561066B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
US4497900A (en) 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens
SE8303035D0 (sv) 1983-05-30 1983-05-30 Alfa Laval Agri Int Anordning vid rormjolkningsanleggning
US4584195A (en) 1984-06-21 1986-04-22 The Board Of Trustees Of The Leland Stanford Junior University Broad spectrum vaccine against gonorrhea
US4622223A (en) * 1984-06-21 1986-11-11 The Board Of Trustees For The Leland Stanford University Broad spectrum vaccine against gonorrhea
NL8403195A (nl) 1984-10-19 1986-05-16 Nederlanden Staat Immunogene complexen en vaccins die deze bevatten.
US4659658A (en) 1984-12-26 1987-04-21 Becton, Dickinson And Company Lectin-coated latex agglutination assay for Neisseria gonorrhoeae
US4707543A (en) 1985-09-17 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine

Also Published As

Publication number Publication date
US6664094B1 (en) 2003-12-16
EP0351604B1 (de) 1994-09-14
EP0351604A1 (de) 1990-01-24
DE68918189D1 (de) 1994-10-20
CA1338708C (en) 1996-11-12

Similar Documents

Publication Publication Date Title
DE68921798T2 (de) Therapeutische Nuleoside.
IT1215765B (it) Dispositivo di emodiafiltrazione erelativo procedimento di emodiafiltrazione.
DK272889D0 (da) Vaccine
DE3785404D1 (de) Impfstoffe.
DE68905354D1 (de) Einstellbarer anschlag.
DK189788D0 (da) Vaccine
FI903105A0 (fi) Vertikal lagerenhet.
DE58901136D1 (de) Turboradialgeblaese.
NO881288L (no) Pasteurella-vaksine.
DE3881993T2 (de) Mycoplasma-Impfstoff.
DE68914043D1 (de) Coccidiosis-Vakzin.
DK16489D0 (da) Immunstimulerende praeparat.
DE68920608T2 (de) Autoklav.
DE68918189D1 (de) Neisseria-Vakzine.
DE3782960T2 (de) Impfstoffe.
NO883319D0 (no) Laaseanordning for stolseter.
DE59002729D1 (de) Sessel.
DE409895T1 (de) Pasteurella-impfstoff.
IT214855Z2 (it) Poltrona.
ATE105483T1 (de) Impfstoff-adjuvans.
ATE83154T1 (de) Impfstoffe.
ES1008462Y (es) Almohada.
IT214504Z2 (it) Sedia vestibile.
IT1226996B (it) Sedia.
IT8819501A0 (it) Cavalletto.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee